These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2487526)

  • 1. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
    Takahashi K; Endoh M; Taira N
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
    Hosono M; Taira N
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):633-40. PubMed ID: 2442528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
    Yoneyama F; Yamada H; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
    Imagawa J; Satoh K; Taira N
    Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of cardiac and coronary vasodilator effects of MS-857, a novel cardiotonic agent, assessed in isolated, blood-perfused heart preparations of the dog.
    Maruyama M; Kamiya J; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):777-82. PubMed ID: 2481193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
    Gotanda K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
    Gotanda K; Yanagisawa T; Satoh K; Taira N
    Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y; Taira N
    Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
    Wada Y; Satoh K; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular profile of AN-132, a new diamine derivative antiarrhythmic agent, revealed in the isolated, blood-perfused dog heart.
    Gotanda K; Satoh K; Taira N
    Tohoku J Exp Med; 1988 Sep; 156(1):65-78. PubMed ID: 3194907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.